Executive Director Global Ascvd
Deliver mid/long-term brand expansion strategies for the atherosclerosis franchise▪ Led Cardiovascular long-term portfolio strategy development team resulting in approved 20-year plan▪ Led successful FDP evaluation and recommendation for CVOT supporting LEQVIO in primary prevention▪ Established and led 5+ cross-functional sub-teams evaluating potential LCM opportunities▪ Provided ad-interim global commercial leadership for pelacarsen (5 months)